Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy

Por Raizer, Jeffrey J., Malkin, Mark G., Kleber, Martin, Abrey, Lauren E.
Publicado em 2004

Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri

Por Ellingson, Benjamin M., Rand, Scott D., Malkin, Mark G., Schmainda, Kathleen M.
Publicado em 2009

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.

Por Khan, Raja B., Raizer, Jeffrey J., Malkin, Mark G., Bazylewicz, Kimberley A., Abrey, Lauren E.
Publicado em 2002

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

Por Schmainda, Kathleen M., Prah, Melissa, Connelly, Jennifer, Rand, Scott D., Hoffman, Raymond G., Mueller, Wade, Malkin, Mark G.
Publicado em 2014

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

Por Ellingson, Benjamin M., Malkin, Mark G., Rand, Scott D., LaViolette, Pete S., Connelly, Jennifer M., Mueller, Wade M., Schmainda, Kathleen M.
Publicado em 2010

The Effects of Perfusion on Diffusion Changes in Human Brain Tumors

Por Cohen, Alexander D., LaViolette, Peter S., Prah, Melissa, Connelly, Jennifer, Malkin, Mark G., Rand, Scott D., Mueller, Wade M., Schmainda, Kathleen M.
Publicado em 2013

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

Por Ellingson, Benjamin M., Malkin, Mark G., Rand, Scott D., Connelly, Jennifer M., Quinsey, Carolyn, LaViolette, Pete S., Bedekar, Devyani P., Schmainda, Kathleen M.
Publicado em 2010

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma

Por LaViolette, Peter S., Cohen, Alex D., Prah, Melissa A., Rand, Scott D., Connelly, Jennifer, Malkin, Mark. G., Mueller, Wade. M., Schmainda, Kathleen M.
Publicado em 2013

Spatially Quantifying Microscopic Tumor Invasion and Proliferation Using a Voxel-Wise Solution to a Glioma Growth Model and Serial Diffusion MRI

Por Ellingson, Benjamin M., LaViolette, Peter S., Rand, Scott D., Malkin, Mark G., Connelly, Jennifer M., Mueller, Wade M., Prost, Robert W., Schmainda, Kathleen M.
Publicado em 2010

Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade gliom...

Por LaViolette, Peter S., Mickevicius, Nikolai J., Cochran, Elizabeth J., Rand, Scott D., Connelly, Jennifer, Bovi, Joseph A., Malkin, Mark G., Mueller, Wade M., Schmainda, Kathleen M.
Publicado no Neuro Oncol (2014)

Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics

Por Heroux, Maxime S., Chesnik, Marla A., Halligan, Brian D., Al-Gizawiy, Mona, Connelly, Jennifer M., Mueller, Wade M., Rand, Scott D., Cochran, Elizabeth J., LaViolette, Peter S., Malkin, Mark G., Schmainda, Kathleen M., Mirza, Shama P.
Publicado no Physiol Genomics (2014)

A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma

Por Nghiemphu, Phioanh Leia, Wen, Patrick Y., Lamborn, Kathleen R., Drappatz, Jan, Robins, H. Ian, Fink, Karen, Malkin, Mark G., Lieberman, Frank S., DeAngelis, Lisa M., Torres-Trejo, Alejandro, Chang, Susan M., Abrey, Lauren, Fine, Howard A., Demopoulos, Alexis, Lassman, Andrew B., Kesari, Santosh, Mehta, Minesh P., Prados, Michael D., Cloughesy, Timothy F.
Publicado em 2010